Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Merck to Sell Generic Enbrel

By Drug Discovery Trends Editor | June 13, 2011

WHITEHOUSE STATION, N.J. (AP) – Merck & Co. will team up with a South Korean company to study and sell a generic version of the rheumatoid arthritis and psoriasis drug Enbrel, the company said.

Merck did not disclose financial terms of its agreement with Hanwha Chemical Corp. Hanwha developed the generic, which is being studied in a late-stage clinical trial in placebo to demonstrate in works as well as Enbrel as part of a regimen for rheumatoid arthritis. Merck will handle clinical development and manufacturing in all countries except South Korea and Turkey. Hanwha will get an upfront payment and could get payments for technology transfer, development milestones, and royalties on any sales.

Enbrel, or etanercept, is sold by Amgen Inc. in the U.S. and Pfizer Inc. in the rest of the world. It is a biotech drug, meaning it is made inside living cells. Traditional pharmaceuticals are made from chemical compounds and they are simpler to manufacture.

Date: June 13, 2011
Source: Associated Press


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50